Astri Dewayani

Astri Dewayani

Auto-generated profile, based on publicly available information

Astri Dewayani

Department of Infectious Disease Control, Faculty of Medicine, Oita University, Oita, 879-5593, Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2021 in Toxins
Verified
Journal Article
Open access
PDF file
ADAstri Dewayani
Astri Dewayani
KFKartika Afrida Fauzia
Kartika Afrida Fauzia
Ricky Indra AlfarayRicky Indra Alfaray
Ricky Indra Alfaray
LWLanggeng Agung Waskito
Langgeng Agung Waskito
DDDalla Doohan
Dalla Doohan
MMMuhammad Miftahussurur
Muhammad Miftahussurur
Although millions of people have been infected by Helicobacter pylori (H. pylori), only a small proportion of infected individuals will develop adverse outcomes, ranging from chronic gastritis to gastric cancer. Advanced development of the disease has been well-linked with chronic inflammation, which is significantly impacted by the adaptive and humoral immunity response. From the perspective of cellular immunity, this review aims to clarify the intricate axis between IL-17, IL-21, and IL-23 in H. pylori-related diseases and the pathogenesis of inflammatory gastrointestinal diseases. CD4+ helper T (Th)-17 cells, with the hallmark pleiotropic cytokine IL-17, can affect antimicrobial activity and the pathogenic immune response in the gut environment. These circumstances cannot be separated, as the existence of affiliated cytokines, including IL-21 and IL-23, help maintain Th17 and accommodate humoral immune cells. Comprehensive understanding of the dynamic interaction between molecular host responses in H. pylori-related diseases and the inflammation process may facilitate further development of immune-based therapy.

30 November 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
NSNozomi Sachi
Nozomi Sachi
NKNaganori Kamiyama
Naganori Kamiyama
BSBenjawan Saechue
Benjawan Saechue
SOSotaro Ozaka
Sotaro Ozaka
ADAstri Dewayani
Astri Dewayani
TKTakashi Kobayashi
Takashi Kobayashi

18 May 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ADAstri Dewayani
Astri Dewayani
KFKartika Afrida Fauzia
Kartika Afrida Fauzia
RARicky Indra Alfaray
Ricky Indra Alfaray
LWLanggeng Agung Waskito
Langgeng Agung Waskito
DDDalla Doohan
Dalla Doohan
MMMuhammad Miftahussurur
Muhammad Miftahussurur
Inadequate antimicrobial treatment has led to multidrug-resistant (MDR) bacteria, including Helicobacter pylori (H. pylori), which one of the notable pathogens in the stomach. Antibiotic-induced changes in the microbiota can negatively affect the host. This study aimed to determine the influence of H. pylori resistance on the diversity and abundance of the stomach microbiome. Bacterial DNA was extracted from biopsy samples of patients presenting dyspepsia symptoms with H. pylori positive from cultures and histology. DNA was amplified from the V3-V4 regions of the 16S rRNA gene. In-vitro E-test was used to detect antibiotic resistance. Microbiome community analysis was conducted through α-diversity, β-diversity, and relative abundance. Sixty-nine H. pylori positive samples were eligible after quality filtering. Following resistance status to five antibiotics, samples were classified into 24 sensitive, 24 single resistance, 16 double resistance, 5 triple resistance. Samples were mostly resistant to metronidazole (73.33%; 33/45). Comparation of four groups displayed significantly elevated α-diversity parameters under the multidrug resistance condition (all P <0.05). A notable change was observed in triple-resistant compared to sensitive (P <0.05) and double-resistant (P <0.05) groups. Differences in β-diversity by UniFrac and Jaccard were not significant in terms of the resistance (P = 0.113 and P = 0.275, respectively). In the triple-resistant group, the relative abundance of Helicobacter genera was lower, whereas that of Streptococcus increased. Moreover, the linear discriminant analysis effect size (LEfSe) was associated with the presence of Corynebacterium and Saccharimonadales in the single-resistant group and Pseudomonas and Cloacibacterium in the triple-resistant group. Our results suggest that the resistant samples showed a higher trend of diversity and evenness than the sensitive samples. The abundance of H. pylori in the triple-resistant samples decreased with increasing cohabitation of pathogenic bacteria, which may support antimicrobial resistance. However, antibiotic susceptibility determined by the E-test may not completely represent the resistance status.

15 June 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SOSotaro Ozaka
Sotaro Ozaka
ASAkira Sonoda
Akira Sonoda
SAShimpei Ariki
Shimpei Ariki
MMMizuki Minata
Mizuki Minata
NKNaganori Kamiyama
Naganori Kamiyama
TKTakashi Kobayashi
Takashi Kobayashi
Antibiotics disrupt normal gut microbiota and cause dysbiosis, leading to a reduction in intestinal epithelial barrier function. Disruption of the intestinal epithelial barrier, which is known as “leaky gut”, results in increased intestinal permeability and contributes to the development or exacerbation of gastrointestinal diseases such as inflammatory bowel disease and irritable bowel syndrome. We have previously reported on a murine model of intestinal epithelial barrier dysfunction associated with dysbiosis induced by the administration of ampicillin and vancomycin. Saireito, a traditional Japanese herbal medicine, is often used to treat autoimmune disorders including ulcerative colitis; the possible mechanism of action and its efficacy, however, remains unclear. In this study, we examined the efficacy of Saireito in our animal model for leaky gut associated with dysbiosis. C57BL/6 mice were fed a Saireito diet for the entirety of the protocol (day1-28). To induce colitis, ampicillin and vancomycin were administered in drinking water for the last seven consecutive days (day22-28). As previously demonstrated, treatment with antibiotics caused fecal occult bleeding, cecum enlargement with black discoloration, colon inflammation with epithelial cell apoptosis, and upregulation of pro-inflammatory cytokines. Oral administration of Saireito significantly improved antibiotics-induced fecal occult bleeding and cecum enlargement by suppressing inflammation in the colon. Furthermore, Saireito treatment ensured the integrity of the intestinal epithelial barrier by suppressing apoptosis and inducing cell adhesion proteins including ZO-1, occludin, and E-cadherin in intestinal epithelial cells, which in turn decreased intestinal epithelial permeability. Moreover, the reduced microbial diversity seen in the gut of mice treated with antibiotics was remarkably improved with the administration of Saireito. In addition, Saireito altered the composition of gut microbiota in these mice. These results suggest that Saireito alleviates leaky gut caused by antibiotic-induced dysbiosis. Our findings provide a potentially new therapeutic strategy for antibiotic-related gastrointestinal disorders.

29 April 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
ADAstri Dewayani
Astri Dewayani
NKNaganori Kamiyama
Naganori Kamiyama
NSNozomi Sachi
Nozomi Sachi
SOSotaro Ozaka
Sotaro Ozaka
BSBenjawan Saechue
Benjawan Saechue
TKTakashi Kobayashi
Takashi Kobayashi

22 July 2020 in Acta Histochemica
Verified
Journal Article
Open access
MMMuhammad Miftahussurur
Muhammad Miftahussurur
DDDalla Doohan
Dalla Doohan
ASAri Syam
Ari Syam
INIswan Abbas Nusi
Iswan Abbas Nusi
LWLanggeng Agung Waskito
Langgeng Agung Waskito
Yoshio YamaokaYoshio Yamaoka
Yoshio Yamaoka
We aimed to validate 2 types of antibodies, anti-CagA antibody and anti-East Asian CagA specific antibody (α-EAS antibody) for the determination of CagA status in Indonesia. We also confirmed the performance of α-EAS antibody for the detection of East Asian-type CagA H. pylori. Immunohistochemistry was performed using anti-CagA antibody and α-EAS antibody on gastric biopsy specimens from a total of 967 Indonesian patients. Diagnostic values of immunohistochemistry were evaluated with PCR-based sequencing as gold standard. Anti-CagA antibody had high sensitivity, specificity, and accuracy (87.0%, 100%, and 98.8%, respectively) for determining CagA status. The α-EAS antibody was not suitable for the purpose of CagA status determination, as it had a low sensitivity (23.9%). High specificity (97.6%) but low sensitivity (41.2%) and accuracy (66.3%) was observed in α-EAS antibody to detect East Asian-type CagA. Patients with positive result of immunohistochemistry using anti-CagA antibody had significantly higher monocyte infiltration score in antrum (P < 0.001) and corpus (P = 0.009). In conclusion, the anti-CagA antibody is still suitable to be used in Indonesia for determining the CagA status, whilst the α-EAS antibody was not appropriate to discriminate between East Asian-type and non-East Asian-type CagA in Indonesia.